SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001100412-15-000013
Filing Date
2015-03-02
Accepted
2015-03-02 08:09:55
Documents
3
Period of Report
2015-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k3215.htm 8-K 38757
2 EXHIBIT 99.1 ex991pr3215.htm EX-99.1 17794
3 arraylogo99.jpg GRAPHIC 38862
  Complete submission text file 0001100412-15-000013.txt   111555
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16633 | Film No.: 15662360
SIC: 2834 Pharmaceutical Preparations